Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: Before and after chemoprophylaxis and institution of HEPA filters
- 22 March 2001
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 66 (4) , 257-262
- https://doi.org/10.1002/ajh.1054
Abstract
Between September 1993 and December 1993, during extensive hospital construction and indoor renovation, a nosocomial outbreak of invasive pulmonary aspergillosis occurred in acute leukemia patients treated in a regular ward that has only natural ventilation. The observed infection rate was 50%. Chemoprophylaxis with intravenous continuous low‐dose amphotericin B was then instituted as a preventive measure. During the next 18 months invasive pulmonary aspergillosis developed in 43% of acute leukemia patients. After that period a new hematology ward was opened with an air filtration system through high‐efficiency particulate air filtration (HEPA) filters, and a bone marrow transplantation program was started on the hematology service. During the following three years, none of the acute leukemia or bone marrow transplantation patients who were hospitalized exclusively in the hematology ward developed invasive pulmonary aspergillosis, although 29% of acute leukemia patients who were housed in a regular ward, because of shortage of space in the new facility, still contracted invasive pulmonary aspergillosis. Overall, 31 patients were diagnosed with invasive pulmonary aspergillosis during almost five years: 74% of patients recovered from invasive pulmonary aspergillosis, and 42% are long‐term survivors; 26% of patients died of resistant leukemia with aspergillosis, but no one died of invasive pulmonary aspergillosis alone. In conclusion, during an on‐going construction period, an extremely high incidence rate of invasive pulmonary aspergillosis in acute leukemia patients undergoing intensive chemotherapy was observed. Institution of low‐dose intravenous amphotericin B prophylaxis marginally reduced the incidence rate of invasive pulmonary aspergillosis. Keeping patients in a special ward with air filtration through a HEPA system eliminated invasive pulmonary aspergillosis completely. Among patients who developed invasive pulmonary aspergillosis, early diagnosis and treatment are probably the explanation for the favorable outcome. Am. J. Hematol. 66:257–262, 2001.Keywords
This publication has 25 references indexed in Scilit:
- Tolerance and efficacy of amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in haematological patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1997
- Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patientsAnnals of Hematology, 1995
- Oral itraconazole plus nasal amphotericin B for prophylaxis of invasive aspergillosis in patients with hematological malignanciesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- Nosocomial Invasive Aspergillosis in Lymphoma Patients Treated with Bone Marrow or Peripheral Stem Cell TransplantsInfection Control & Hospital Epidemiology, 1993
- Fungal infections in cancer patients: An international autopsy surveyEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantationThe American Journal of Medicine, 1991
- Invasive Aspergillus Rhinosinusitis in Patients with Acute LeukemiaClinical Infectious Diseases, 1991
- Incidence of Nosocomial Aspergillosis in Patients with Leukemia Over a Twenty-Year PeriodInfection Control & Hospital Epidemiology, 1989
- AspergillosisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Primary Cutaneous Aspergillosis Associated with Hickman Intravenous CathetersNew England Journal of Medicine, 1987